(Allergan plc)

	AGN latest price $151.5765 (-0.03%) ($148.2715 - $152.0838) on Mon. Dec. 10, 2018.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.77% (three month average)
RSI	39
Latest Price	$151.5765(-0.03%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -0.5% a day on average for past five trading days.
Weekly Trend	AGN declines -0.2% a week on average for past two weeks.
Market Behavior	Rotation from value to growth for large cap. Value stock sell-off for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(50%)    ARKG(47%)    XBI(47%)    XLV(47%)    IVE(45%)
Factors Impacting AGN price	AGN will decline at least -0.885% in a week (0% probabilities).   VIXM(-26%)    TLT(-24%)    UUP(-19%)    DIA(-17%)    VXX(-15%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.885% (StdDev 1.77%)
Hourly BBV	0 ()
Intraday Trend	0.1%

Resistance Level	$155.41
5 Day Moving Average	$153.67(-1.36%)
10 Day Moving Average	$153.6(-1.32%)
20 Day Moving Average	$155.41(-2.47%)
To recent high	-20.9%
To recent low	0.2%
Market Cap	$49.975b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed